Explore professionally built ETF model portfolios. Discover now →

Advertisement
Advertisement

FXHvsFTXHETF Comparison

ETF 1
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
-0.42%
VS
ETF 2
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
-0.42%

First Trust Health Care AlphaDEX Fund ETF (FXH) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. Both ETFs have the same top 1 sector exposures: Healthcare. FXH is more expensive with a Total Expense Ratio (TER) of 0.61%, versus 0.6% for FTXH. FXH is up 16.21% year-to-date (YTD) with +$65M in YTD flows. FTXH performs better with 26.05% YTD performance, and +$1.11B in YTD flows. Run a side-by-side ETF comparison of FXH and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FXH vs FTXH performance and flow charts

Performance

-2.00.02.04.06.0%Aug 17Aug 24Aug 31Sep 8Sep 15

Cumulative Flows

0 M50 M100 M150 MAug 17Aug 24Aug 31Sep 8Sep 15

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/17/2026
1M3MYTD1Y3Y5Y
Perf.
FXH
FTXH
+0.53%+2.91%
+13.98%+16.24%
+16.21%+26.05%
+22.70%+49.52%
+33.57%+63.96%
+7.15%+72.99%
Flows
FXH
FTXH
+$20M+$161M
+$120M+$1.10B
+$65M+$1.11B
+$44M+$1.11B
-$498M+$1.10B
-$437M+$1.10B
Volatility and drawdown
3M1Y3Y5Y
Volatility
FXH
FTXH
+15.66%+19.83%
+15.54%+17.58%
+15.63%+17.00%
+16.94%+16.35%
Max drawdown
FXH
FTXH
-4.40%-5.41%
-12.07%-7.50%
-17.66%-19.32%
-28.28%-19.32%
Max drawdown duration
FXH
FTXH
23d23d
168d99d
395d393d
1742d393d
Trading data

Create an account to view trading data

Join for free
FXH
FTXH
Last sale
9/21/2026 at 1:30 PM
$130.87
$41.33
Previous close
09/18/2026
$130.77
$41.09
Consolidated volume
09/18/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FXH
FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/21/2026 at 1:30 PM
Live
Closed
FXH
FTXH
Last price
$130.87
$41.33
1D performance
+0.08%
+0.59%
AuM$1.15 B$1.19 B
E/R0.61%0.6%
Characteristics
FXH
FTXH
Management strategyPassivePassive
ProviderFirst TrustFirst Trust
BenchmarkStrataQuant Health Care IndexNASDAQ US Smart Pharmaceuticals Index
N° of holdings7249
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateMay 8, 2007September 20, 2016
ESGNoNo
Advertisement
Exposure

Countries

FXH
USA
93.07%
Other
6.93%
FTXH
USA
95.79%
Other
4.21%

Sectors

FXH
Healthcare
98.24%
Other
1.76%
FTXH
Healthcare
99.86%
Other
0.14%
Advertisement

Diversification

FXH

Total weight of top 15 holdings out of 15

35.54%
FTXH

Total weight of top 15 holdings out of 15

66.98%

Top 15 holdings

Data as of July 31, 2026
FXH
Regeneron Pharmaceuticals, Inc.
2.85%
Natera, Inc.
2.57%
Universal Health Services, Inc.
2.50%
Boston Scientific Corp.
2.49%
Pfizer Inc.
2.48%
Solventum Corp.
2.47%
Zimmer Biomet Holdings, Inc.
2.47%
Guardant Health, Inc.
2.41%
Tenet Healthcare Corp.
2.34%
Globus Medical, Inc.
2.33%
Corcept Therapeutics, Inc.
2.24%
Halozyme Therapeutics, Inc.
2.18%
Centene Corp.
2.15%
The Cigna Group
2.14%
Encompass Health Corp.
1.92%
FTXH
Merck & Co., Inc.
7.58%
Eli Lilly & Co.
7.43%
AbbVie, Inc.
7.11%
Johnson & Johnson
6.78%
Bristol Myers Squibb Co.
6.61%
Amgen, Inc.
3.53%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.43%
Viatris, Inc.
3.40%
Regeneron Pharmaceuticals, Inc.
3.34%
Pfizer Inc.
3.17%
Cardinal Health, Inc.
3.14%
Gilead Sciences, Inc.
3.03%
Incyte Corp.
2.48%
United Therapeutics Corp.
2.43%
Frequently asked questions about FXH and FTXH

How have the FXH and FTXH ETFs performed in 2026?

As of September 17, 2026, FXH is up 16.21% year-to-date (YTD), while FTXH has returned 26.05%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: FXH or FTXH?

Year-to-date, the FXH ETF saw +$65M in flows, compared to +$1.11B for FTXH.

Which ETF is more volatile: FXH or FTXH?

Over the past year, FXH had a volatility of 15.54%, while FTXH experienced 17.58%.

Which ETF is bigger: FXH or FTXH?

As of September 17, 2026, FXH holds $1.15 B in assets under management (AUM), while FTXH manages $1.19 B.

What sectors do the FXH and FTXH ETFs invest in?

FXH leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the FXH ETF and FTXH ETF?

FXH top holdings include Regeneron Pharmaceuticals, Inc., Natera, Inc. and Universal Health Services, Inc.. FTXH holds in its top three: Merck & Co., Inc., Eli Lilly & Co. and AbbVie, Inc..

Which ETF is more diversified: FXH or FTXH?

FXH holds 72 securities with 35.54% of its assets in the top 15. FTXH has 49 securities and a top 15 weight of 66.98%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder